Given the role of NF-κB in different cancer types, and the fact that NF-κB transcriptional factors are constitutively activated in the majority of PDACs, it is likely that NF-κB-driven pathways are involved in the regulation of numerous aspects of PDAC development and progression. Here, NFKB1 is linked to cancer.